Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV000507032 | SCV000603659 | uncertain significance | not specified | 2017-03-02 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001176834 | SCV001340895 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2023-04-05 | criteria provided, single submitter | clinical testing | This missense variant replaces arginine with histidine at codon 743 of the FBN1 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with cardiovascular disorders in the literature. This variant has been identified in 5/282808 chromosomes in the general population by the Genome Aggregation Database (gnomAD). A different missense variant occurring at the same codon, p.Arg743Cys, is thought to be disease-causing (ClinVar variation ID: 199993). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |
Labcorp Genetics |
RCV001857268 | SCV002182977 | likely benign | Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection | 2023-09-29 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002481638 | SCV002781356 | uncertain significance | Ectopia lentis 1, isolated, autosomal dominant; Marfan syndrome; MASS syndrome; Stiff skin syndrome; Weill-Marchesani syndrome 2, dominant; Acromicric dysplasia; Geleophysic dysplasia 2; Progeroid and marfanoid aspect-lipodystrophy syndrome | 2021-09-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001176834 | SCV003863101 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2023-02-08 | criteria provided, single submitter | clinical testing | The p.R743H variant (also known as c.2228G>A), located in coding exon 18 of the FBN1 gene, results from a G to A substitution at nucleotide position 2228. The arginine at codon 743 is replaced by histidine, an amino acid with highly similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Prevention |
RCV004535641 | SCV004113074 | uncertain significance | FBN1-related disorder | 2022-08-29 | criteria provided, single submitter | clinical testing | The FBN1 c.2228G>A variant is predicted to result in the amino acid substitution p.Arg743His. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0085% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/15-48789528-C-T). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |
All of Us Research Program, |
RCV004003558 | SCV004814907 | uncertain significance | Marfan syndrome | 2023-11-02 | criteria provided, single submitter | clinical testing | This missense variant replaces arginine with histidine at codon 743 of the FBN1 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with cardiovascular disorders in the literature. This variant has been identified in 5/282808 chromosomes in the general population by the Genome Aggregation Database (gnomAD). A different missense variant occurring at the same codon, p.Arg743Cys, is thought to be disease-causing (ClinVar variation ID: 199993). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |
Gene |
RCV004722847 | SCV005333555 | uncertain significance | not provided | 2023-08-18 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 31227806) |